Skip to main content
. 2023 Oct 4;25(Suppl 4):iv1–iv99. doi: 10.1093/neuonc/noad149

Table 20.

Sixteen-Year Total Deaths, and Median Survival in Months with 95% Confidence Intervals for Primary Malignant Brain and Other CNS Tumor Selected Histopathologies, CBTRUS Statistical Report: NPCR, 2001-2019

Histopathology N Deaths Median Survival (95% CI)
Diffuse astrocytoma 24,819 13,755 63 (60-66)
Anaplastic astrocytoma 17,735 12,514 21 (20-21)
Glioblastoma 146,320 131,036 8 (8-9)
Oligodendroglioma 11,926 3,780 205 (196-209)
Anaplastic oligodendroglioma 5,339 2,533 108 (101-116)
Oligoastrocytic tumors 6,617 3,504 113 (107-120)
Pilocytic astrocytoma 312 1 *** (**-**)
Unique astrocytoma variants 2,484 422 ** (**-**)
Ependymal tumors 18,645 3,407 ** (**-**)
Glioma malignant, NOS 20,839 10,035 95 (86-104)
Choroid plexus tumors 2,285 358 ** (**-**)
Other neuroepithelial tumors 280 84 215 (198-**)
Neuronal and mixed neuronal-glial tumors 12,725 1,619 ** (**-**)
Tumors of the pineal region 1,948 538 ** (216-**)
Embryonal tumors 10,595 4,204 ** (**-**)
Medulloblastoma 7,007 2,075 ** (**-**)
Atypical teratoid/rhabdoid tumor 1,129 726 14 (12-17)
Other embryonal tumors 2,459 1,403 43 (36-50)
Nerve sheath tumors 89,222 9,235 ** (**-**)
Other tumors of cranial and spinal nerves 69 8 ** (**-**)
Meningiomas 398,870 114,855 184 (181-186)
Mesenchymal tumors 16,523 3,054 ** (**-**)
Primary melanocytic lesions 282 171 30 (22-60)
Lymphoma 20,028 13,624 16 (16-18)
Other hematopoietic neoplasms 196 96 138 (94-**)
Germ cell tumor 3,601 529 ** (**-**)
Tumors of the pituitary 179,087 22,448 ** (**-**)
Craniopharyngioma 7,997 1,724 ** (**-**)
Hemangioma 8,891 1,029 ** (**-**)
Neoplasm, unspecified 29,036 16,254 45 (42-49)
All other 1,285 222 ** (**-**)

* ** Cannot be calculated due to median survival not being observed.

-- Survival estimates are not presented when fewer than 100 cases were reported for the specific category.

Abbreviations: CBTRUS, Central Brian Tumor Registry of the United States; CI, confidence interval; NOS, not otherwise specified; NPCR, National Program of Cancer Registries; SEER, Surveillance, Epidemiology, and End Results Program.